Header Logo

Connection

DAVID BATES to Cytochrome P-450 CYP2C19 Inhibitors

Back to Details
This is a "connection" page, showing publications DAVID BATES has written about Cytochrome P-450 CYP2C19 Inhibitors.
DAVID BATES
Connection Strength
0.148
Cytochrome P-450 CYP2C19 Inhibitors
  1. Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis. Drug Saf. 2017 10; 40(10):923-932.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.